The complex of myxomas, spotty pigmentation, and endocrine overactivity
about
Molecular genetics of adrenocortical tumor formation and potential pharmacologic targetsCarney complex: an updateCardiac tumors: echo assessmentOsteochondromyxoma: Review of a rare carney complex criterionMEN1, MEN4, and Carney Complex: Pathology and Molecular GeneticsPancreatic ductal and acinar cell neoplasms in Carney complex: a possible new associationSpotty skin pigmentation and multiple blue naevi as cutaneous markers for spinal melanotic schwannoma.The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlationRecurrent right ventricular cardiac myxoma in a patient with Carney complex: a case report.Imaging in Cushing's syndrome.Cutaneous signs are important in the diagnosis of the rare neoplasia syndrome Carney complexCushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout miceSurgical Experience of Primary Cardiac Tumor: Single-Institution 23-Year Report.Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?A case of large cell calcifying Sertoli cell tumor in a child with a history of nasal myxoid tumor in infancy.Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A).Molecular genetic diagnosis of the familial myxoma syndrome (Carney complex).Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signalingThe role of mast cell tryptases in cardiac myxoma: Histogenesis and development of a challenging tumorRegulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.Novel PRKAR1A gene mutations in Carney Complex."Syndrome myxoma": a subset of patients with cardiac myxoma associated with pigmented skin lesions and peripheral and endocrine neoplasms.Large-cell calcifying Sertoli cell tumors of the testes in pediatrics.Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshopPRKAR1A and the evolution of pituitary tumors.Malignant large cell calcifying sertoli cell tumor of testis with skip metastasis to lung presented with peutz-jeghers syndrome.Mouse models of endocrine tumours.Solid tumors associated with multiple endocrine neoplasias.Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).Oral pigmentation.Conjunctival myxoma, Zollinger-Ellison syndrome and abnormal thickening of the inter-atrial septum: a case report and review of the literature.Genetic background of adrenocortical tumor development.Carney complex and other conditions associated with micronodular adrenal hyperplasias.What syndrome is this? Peutz-Jeghers syndrome.Carney complex (CNC).Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.Carney-Complex: multiple resections of recurrent cardiac myxomaMolecular and genetic aspects of odontogenic lesions.How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
P2860
Q26849995-8AEBA845-AC5A-4D5D-9E6D-22E36177F15AQ27026529-26BE3D7E-A13E-4271-BE41-5627F1DAC52AQ28067218-88EA71AE-9DC6-41F8-909E-8124AD67D9E8Q28073245-C7DFA1D9-6FFE-4C72-8376-F87B700AA610Q28088746-6A6B0D4F-A604-4469-81F9-BDEB57E9D597Q28247409-2FE1072A-47D1-4E52-AE6F-B67CEBE86824Q30389199-22B57F32-98B5-460E-8B9B-0BDADA4AA548Q30457896-8D9C230A-4B8F-447D-9A64-A9301CE0EA6EQ30579140-41CD5C23-E867-4D84-B8A5-A83F16289242Q31143344-F95C7660-5839-461A-B26E-4EEAB6B5AA05Q33409532-08712DC5-331A-40D0-A443-766842AD86EBQ33604822-3A0C9D53-8A38-45B9-BD10-C530EDEEC218Q33662254-1BE2E8CD-7697-47B1-8C2E-8C210A14B337Q33688180-D48B335C-EF72-4FE5-BCB8-4147A585D2FAQ33694047-6A8ADF0F-E2E4-4B6F-9B8F-42E06A0DA0E2Q33701874-05BFF569-3889-41AB-8D25-E098751EA067Q33707258-277EC988-F37B-4141-B551-627377DA70C4Q33755811-75CB95CB-9FE3-4692-B540-852B5CD23320Q33778558-FF4150BE-4136-40F2-B1C2-D40A29B649DFQ33909917-07915D46-8481-4D2A-850D-17ACE9DE543FQ33962052-E630B509-6224-4C79-B089-A4E4E8A722E5Q33999260-0D8AE0B4-0C0F-4344-BF72-F4398B06A51AQ34045351-0A6F327E-75AC-479B-90AE-2F6FECE8338DQ34055579-C15ACCDC-9158-4FD0-AF7F-E87C7570C828Q34070989-1E923561-8BBC-4780-92C8-C699749800A7Q34126680-B0C0C2BD-F162-4CE4-8318-CA3A1EDBC2A2Q34129129-49A86295-AC91-4766-9BB8-C295EAEC196BQ34213017-6CDCC57C-7CE0-4CC1-B356-930C67354FBEQ34283507-E8C2BC80-EE12-4B9A-9EA0-0EEACDD2586FQ34285768-34369EB2-48A9-4503-837B-DBA1E6C6AFBFQ34303065-29771644-5E42-4717-9BAD-91327BEF6917Q34307022-F31FDCE9-C38F-4F6E-B0C5-64457D5494C8Q34381188-765ADBFC-0C1B-4CF1-B976-781FCEC98A98Q34398710-400B11DC-23B0-41F5-8F2A-C0F6702B160AQ34549713-CDEDF9AC-A2FA-4040-9603-4E7F517898BDQ34568138-42C2024A-EF13-4A66-88FF-29CE4BBF1EF8Q34571810-FEB808EB-3B0C-4B6E-A926-514EBB274B0CQ34573707-672AE1AE-7ED7-44B1-845D-F1D4F173CB1BQ34577342-8D1FFF21-0CFB-4403-B9BB-83CACB7B0FB4Q34629130-EF2CE6CC-B4FE-4D15-94A4-0E2A66CE0CB5
P2860
The complex of myxomas, spotty pigmentation, and endocrine overactivity
description
1985 nî lūn-bûn
@nan
1985 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@ast
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@en
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@nl
type
label
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@ast
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@en
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@nl
prefLabel
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@ast
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@en
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@nl
P2093
P3181
P1433
P1476
The complex of myxomas, spotty pigmentation, and endocrine overactivity
@en
P2093
P304
P3181
P356
10.1097/00005792-198507000-00007
P407
P577
1985-07-01T00:00:00Z